Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in Familial Adenomatous Polyposis
NCT00248053Phase 2Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Nov 2005
- Primary completion
- Jun 2008
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of curcumin in familial adenomatous polyposis (FAP), sponsored by Johns Hopkins University. Planned start Nov 2005; status: withdrawn.
02
Drugs
curcumin
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT00248053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248053.